<?xml version="1.0" encoding="UTF-8"?>
<p>ROS changes could reflect the status of oxidative function, which can be a measure of oxidative tissue and cell damage (Li et al. 
 <xref rid="CIT0019" ref-type="bibr">2019</xref>). The results of DHE-ROS measurement revealed that RosA could significantly reduce ROS production in myocardial I/R injury areas (225.6 ± 37.1% vs. 319.7 ± 27.1%, 
 <xref ref-type="fig" rid="F0006">Figure 6(A,C)</xref>). Additionally, RosA was found to reduce ROS production following OGD/R injury in cells (213.9 ± 32.2% vs. 379.1 ± 44.2%, 
 <xref ref-type="fig" rid="F0006">Figure 6(B,D)</xref>).
</p>
